Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Lodge

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2010
Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatmentPauline Belujon, Daniel J Lodge, Anthony A Grace
Developmental Neurobiology|February 21, 2014
An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophreniaLi Chen, Stephanie M Perez, Daniel J Lodge
Psychoneuroendocrinology|July 9, 2014
Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophreniaStephanie M Perez, Li Chen, Daniel J Lodge
Journal of Psychopharmacology (Oxford, England)|October 30, 2015
THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophreniaDavid D Aguilar, Andrea Giuffrida, Daniel J Lodge
The International Journal of Neuropsychopharmacology|January 13, 2018
Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia SusceptibilityDavid D Aguilar, Andrea Giuffrida, Daniel J Lodge
Translational Psychiatry|October 23, 2019
Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophreniaStephanie M Perez, Angela Boley, Daniel J Lodge
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2018
Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autismJennifer J Donegan, Angela M Boley, Daniel J Lodge
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2009
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophreniaDaniel J Lodge, Margarita M Behrens, Anthony A Grace
Behavioural Brain Research|January 21, 2019
Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed ratsStephanie M Perez, Jennifer J Donegan, Daniel J Lodge
Schizophrenia Research|June 4, 2014
A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophreniaAngela M Boley, Stephanie M Perez, Daniel J Lodge
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2010
Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatmentPauline Belujon, Daniel J Lodge, Anthony A Grace
Developmental Neurobiology|February 21, 2014
An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophreniaLi Chen, Stephanie M Perez, Daniel J Lodge
Psychoneuroendocrinology|July 9, 2014
Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophreniaStephanie M Perez, Li Chen, Daniel J Lodge
Journal of Psychopharmacology (Oxford, England)|October 30, 2015
THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophreniaDavid D Aguilar, Andrea Giuffrida, Daniel J Lodge
The International Journal of Neuropsychopharmacology|January 13, 2018
Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia SusceptibilityDavid D Aguilar, Andrea Giuffrida, Daniel J Lodge
Translational Psychiatry|October 23, 2019
Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophreniaStephanie M Perez, Angela Boley, Daniel J Lodge
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2018
Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autismJennifer J Donegan, Angela M Boley, Daniel J Lodge
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2009
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophreniaDaniel J Lodge, Margarita M Behrens, Anthony A Grace
Behavioural Brain Research|January 21, 2019
Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed ratsStephanie M Perez, Jennifer J Donegan, Daniel J Lodge
Schizophrenia Research|June 4, 2014
A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophreniaAngela M Boley, Stephanie M Perez, Daniel J Lodge
Pageof 8